Researchers at ETH Zurich combined two CRISPR-Cas methods to decipher how mutations in a cell’s genome affect its function.

In recent years, scientists have created a range of new methods based on CRISPR-Cas technology for precisely editing the ...

Find out what is driving the slowdown in gene therapy investment, as the sector continues to struggle with widespread layoffs ...

A new study has made significant strides in plant genome editing by developing an A-to-K base editing system for rice and ...

On October 16, a biotechnology company in Massachusetts in the U.S. named Wave Life Sciences made headlines for becoming the ...

Life Sciences Center (LSC) have discovered a unique way for cells to silence specific genes without cutting DNA. This ...

University of Wisconsin–Madison researchers targeting a group of hereditary neurodegenerative diseases have found success ...

A Seattle biotech company is working on a tweak to gene expression that could shut down hepatitis B (HBV), one of the viruses ...

An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics ...

The CRISPR tool is capable of repairing the genetic defect responsible for the immune disease chronic granulomatous disease.

Patient-derived organoids (PDOs) are revolutionizing cancer research, enhancing drug testing and personalized treatment ...

Analyst Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Verve Therapeutics (VERV – Research Report) and decreased the ...